Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
Emerging Infectious Diseases
|
January 26, 2013
High seroprevalence for typhus group rickettsiae, southwestern Tanzania
Tatjana Dill, Gerhard Dobler, Elmar Saathoff, et al.
Plos Neglected Tropical Diseases
|
April 8, 2015
High seroprevalence for spotted fever group rickettsiae, is associated with higher temperatures and rural environment in Mbeya region, Southwestern Tanzania
Norbert Heinrich, Tatjana Dill, Gerhard Dobler, et al.
Frontiers in Immunology
|
October 3, 2022
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy
Khalide Azam, Celso Khosa, Sofia Viegas, et al.
Journal of Clinical Microbiology
|
April 19, 2013
Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity
Xavier A Kayigire, Sven O Friedrich, Amour Venter, et al.
Clinical Microbiology Reviews
|
March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies
Jan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
Tuberculosis (Edinburgh, Scotland)
|
May 22, 2018
The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay
Andrea Rachow, Elmar Saathoff, Bariki Mtafya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 11, 2023
Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience
Francesca Saluzzo, Juan Espinosa-Pereiro, Stephan Dressler, et al.
Journal of Clinical Microbiology
|
May 30, 2014
The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment
Isobella Honeyborne, Bariki Mtafya, Patrick P J Phillips, et al.
Plos One
|
January 8, 2020
A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
Markus Beutler, Sara Plesnik, Marina Mihalic, et al.
The Journal of Infection
|
July 11, 2016
Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children
Christian Pohl, Liliana K Rutaihwa, Frederick Haraka, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
Emerging Infectious Diseases
|
January 26, 2013
High seroprevalence for typhus group rickettsiae, southwestern Tanzania
Tatjana Dill, Gerhard Dobler, Elmar Saathoff, et al.
Plos Neglected Tropical Diseases
|
April 8, 2015
High seroprevalence for spotted fever group rickettsiae, is associated with higher temperatures and rural environment in Mbeya region, Southwestern Tanzania
Norbert Heinrich, Tatjana Dill, Gerhard Dobler, et al.
Frontiers in Immunology
|
October 3, 2022
Reduction of blood C-reactive protein concentration complements the resolution of sputum bacillary load in patients on anti-tuberculosis therapy
Khalide Azam, Celso Khosa, Sofia Viegas, et al.
Journal of Clinical Microbiology
|
April 19, 2013
Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity
Xavier A Kayigire, Sven O Friedrich, Amour Venter, et al.
Clinical Microbiology Reviews
|
March 21, 2022
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies
Jan Heyckendorf, Sophia B Georghiou, Nicole Frahm, et al.
Tuberculosis (Edinburgh, Scotland)
|
May 22, 2018
The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay
Andrea Rachow, Elmar Saathoff, Bariki Mtafya, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 11, 2023
Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience
Francesca Saluzzo, Juan Espinosa-Pereiro, Stephan Dressler, et al.
Journal of Clinical Microbiology
|
May 30, 2014
The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment
Isobella Honeyborne, Bariki Mtafya, Patrick P J Phillips, et al.
Plos One
|
January 8, 2020
A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
Markus Beutler, Sara Plesnik, Marina Mihalic, et al.
The Journal of Infection
|
July 11, 2016
Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children
Christian Pohl, Liliana K Rutaihwa, Frederick Haraka, et al.
Page
of 9